Drug Delivery and Translational Research

, Volume 2, Issue 5, pp 406–414 | Cite as

An antibody fragment functionalized dendritic PEGylated poly(2-(dimethylamino)ethyl diacrylate) as a vehicle of exogenous microRNA

  • M. Monaghan
  • U. Greiser
  • H. Cao
  • W. WangEmail author
  • A. PanditEmail author
Research Article


The translation of interfering RNA to the clinic requires more effective delivery agents to enable safe and efficient delivery. The aim of this work was to create a multi-functional delivery agent using deactivation enhanced ATRP synthesis of poly(dimethylamino)ethyl methacrylate (pDMAEMA)-co-PEGMEA/PEGDA (pD-b-P/DA) with linear pDMAEMA as a macro-initiator. The pD-b-P/DA was characterized for its potential to bind synthetic microRNA mimics to form structures and reacted with antibody-derived fragments (Fabs) using Michael-type addition. Conjugation of antibody fragments was verified using SDS–PAGE. Functional delivery of these interfering RNA complexes was proven using a dual luciferase reporter assay. Functional silencing of a reporter gene was improved by complexation of microRNA mimics with pD-b-P/DA alone and with Fab-decorated pD-b-P/DA. The improved silencing with Fab-decorated pD-b-P/DA was evident at 48 h but disappeared at 96 h. The resultant agent enables complexation of nucleic acid (microRNA mimic) and facile conjugation of antibody fragments via a Michael-type addition. In conclusion, this platform is effective at silencing in this reporter system and has potential as an effective delivery system of interfering RNA.


RNA interference Dendritic polymers Antibody conjugation Deactivation enhanced ATRP Gene therapy 



Acknowledgement is given to Science Foundation Ireland, grant no. 07/SRC/B1163, and the College of Engineering and Informatics, National University of Ireland, Galway. Acknowledgement is also due to Dr. Yu Zheng and Ms. Asha Matthew for technical advice.

Supplementary material

13346_2012_97_MOESM1_ESM.pdf (728 kb)
ESM 1 (DOCX 4356 kb)


  1. 1.
    Shan Z-X, Lin Q-X, Fu Y-H, Deng C-Y, Zhou Z-L, Zhu J-N, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun. 2009;381(4):597–601.PubMedCrossRefGoogle Scholar
  2. 2.
    Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther. 2011;19(6):1116–22.PubMedCrossRefGoogle Scholar
  3. 3.
    van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105(35):13027–32.PubMedCrossRefGoogle Scholar
  4. 4.
    Yekta S, I-h S, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science. 2004;304(5670):594–6.PubMedCrossRefGoogle Scholar
  5. 5.
    Monaghan M, Pandit A. RNA interference therapy via functionalized scaffolds. Adv Drug Deliv Rev. 2011;63(4–5):197–208.PubMedCrossRefGoogle Scholar
  6. 6.
    Manjunath N, Wu H, Subramanya S, Shankar P. Lentiviral delivery of short hairpin RNAs. Adv Drug Deliv Rev. 2009;61(9):732–45.PubMedCrossRefGoogle Scholar
  7. 7.
    Tomlinson E, Rolland AP. Controllable gene therapy pharmaceutics of non-viral gene delivery systems. J Control Release. 1996;39(2–3):357–72.CrossRefGoogle Scholar
  8. 8.
    Rahbek UL, Howard KA, Oupicky D, Manickam DS, Dong M, Nielsen AF, et al. Intracellular siRNA and precursor miRNA trafficking using bioresponsive copolypeptides. J Gene Med. 2008;10(1):81–93.PubMedCrossRefGoogle Scholar
  9. 9.
    Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, et al. miR-22 represses cancer progression by inducing cellular senescence. J Cell Biol. 2011;193(2):409–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, et al. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther. 2011;10(8):1470–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Huang Y-H, Bao Y, Peng W, Goldberg M, Love K, Bumcrot DA, et al. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci U S A. 2009;106(9):3426–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Davis ME, Zuckerman JE, Choi CHJ, Seligson D, Tolcher A, Alabi CA, et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature. 2010;464(7291):1067–70.PubMedCrossRefGoogle Scholar
  13. 13.
    Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release. 2008;129(2):107–16.PubMedCrossRefGoogle Scholar
  14. 14.
    Nelson AL, Dhimolea E, Reichert JM. Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov. 2010;9(10):767–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Heggli M, Tirelli N, Zisch A, Hubbell JA. Michael-type addition as a tool for surface functionalization. Bioconjug Chem. 2003;14(5):967–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Zheng Y, Cao H, Newland B, Dong Y, Pandit A, Wang W. 3D single cyclized polymer chain structure from controlled polymerization of multi-vinyl monomers: beyond Flory–Stockmayer theory. J Am Chem Soc. 2011;133(33):13130–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Newland B, Zheng Y, Jin Y, Abu-Rub M, Cao H, Wang W, et al. Single cyclized molecule versus single branched molecule: a simple and efficient 3D “knot” polymer structure for nonviral gene delivery. J Am Chem Soc. 2012;134(10):4782–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Newland B, Tai H, Zheng Y, Velasco D, Di Luca A, Howdle SM, et al. A highly effective gene delivery vector—hyperbranched poly(2-(dimethylamino)ethyl methacrylate) from in situ deactivation enhanced ATRP. Chem Commun. 2010;46(26):4698–700.CrossRefGoogle Scholar
  19. 19.
    Lu B, Mahmud H, Maass AH, Yu B, van Gilst WH, de Boer RA, et al. The Plk1 inhibitor BI 2536 temporarily arrests primary cardiac fibroblasts in mitosis and generates aneuploidy. PLoS One. 2010;5(9):e12963.PubMedCrossRefGoogle Scholar
  20. 20.
    O’Dwyer R, Razzaque R, Hu X, Hollingshead S, Wall J. Engineering of cysteine residues leads to improved production of a human dipeptidase enzyme in E. coli. Appl Biochem Biotechnol. 2009;159(1):178–90.PubMedCrossRefGoogle Scholar

Copyright information

© Controlled Release Society 2012

Authors and Affiliations

  1. 1.Network of Excellence for Functional BiomaterialsNational University of IrelandGalwayIreland

Personalised recommendations